Published in J Am Soc Echocardiogr on December 11, 2008
Development of an echocardiographic risk-stratification index to predict heart failure in patients with stable coronary artery disease: the Heart and Soul study. JACC Cardiovasc Imaging (2009) 2.38
Safety and efficacy of an injectable extracellular matrix hydrogel for treating myocardial infarction. Sci Transl Med (2013) 1.69
Predicting heart failure hospitalization and mortality by quantitative echocardiography: is body surface area the indexing method of choice? The Heart and Soul Study. J Am Soc Echocardiogr (2010) 1.42
Surgical ventricular restoration for the treatment of heart failure. Nat Rev Cardiol (2012) 0.89
The immunosuppressant FTY720 prolongs survival in a mouse model of diet-induced coronary atherosclerosis and myocardial infarction. J Cardiovasc Pharmacol (2014) 0.88
Materials science and tissue engineering: repairing the heart. Mayo Clin Proc (2013) 0.87
Clinical effects of Xinmailong therapy in patients with chronic heart failure. Int J Med Sci (2013) 0.87
Left ventricle: fully automated segmentation based on spatiotemporal continuity and myocardium information in cine cardiac magnetic resonance imaging (LV-FAST). Biomed Res Int (2015) 0.83
Principles of transthoracic echocardiographic evaluation. Nat Rev Cardiol (2015) 0.80
Echocardiographic evaluation of systolic heart failure. Australas J Ultrasound Med (2015) 0.75
Gaining respect for echocardiographic volumetric quantitation: observations on a study of the baseline echocardiography data from the STICH echocardiography core laboratory. J Am Soc Echocardiogr (2012) 0.75
Clinical effects of combined treatment by optimal dose of furosemide and spironolactone on diastolic heart failure in elderly patients. Exp Ther Med (2015) 0.75
The impact of cardiovascular risk factors on cardiac structure and function: Insights from the UK Biobank imaging enhancement study. PLoS One (2017) 0.75
Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics (1988) 70.41
Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr (2005) 46.32
The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med (2005) 20.72
The natural history of congestive heart failure: the Framingham study. N Engl J Med (1971) 13.94
Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA (2003) 13.79
Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr (2003) 11.88
Heart failure. N Engl J Med (2003) 9.75
Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation (1987) 7.14
Depressive symptoms and health-related quality of life: the Heart and Soul Study. JAMA (2003) 7.01
Chronic heart failure in the United States: a manifestation of coronary artery disease. Circulation (1998) 3.68
Assessment of systolic and diastolic ventricular properties via pressure-volume analysis: a guide for clinical, translational, and basic researchers. Am J Physiol Heart Circ Physiol (2005) 3.15
Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction. N Engl J Med (1997) 2.81
Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril. Circulation (1994) 2.74
Assessment of left ventricular ejection fraction and volumes by real-time, two-dimensional echocardiography. A comparison of cineangiographic and radionuclide techniques. Circulation (1979) 2.30
Quantitative echocardiographic determinants of clinical outcome in asymptomatic patients with aortic regurgitation: a prospective study. JACC Cardiovasc Imaging (2008) 2.24
Left ventricular volume from paired biplane two-dimensional echocardiography. Circulation (1979) 2.08
Navigating the crossroads of coronary artery disease and heart failure. Circulation (2006) 2.06
The relationships of left ventricular ejection fraction, end-systolic volume index and infarct size to six-month mortality after hospital discharge following myocardial infarction treated by thrombolysis. J Am Coll Cardiol (2002) 1.96
End-systolic pressure/volume ratio: a new index of ventricular contractility. Am J Cardiol (1977) 1.62
"Diastolic heart failure" or heart failure caused by subtle left ventricular systolic dysfunction? Heart (2002) 1.35
Reproducibility of quantitative two-dimensional echocardiography. Am Heart J (1988) 1.25
Echocardiography in heart failure: applications, utility, and new horizons. J Am Coll Cardiol (2007) 1.24
Approaches to determination of left ventricular volume and ejection fraction by real-time two-dimensional echocardiography. Clin Cardiol (1979) 1.21
End-systolic volume and long-term survival after coronary artery bypass graft surgery in patients with impaired left ventricular function. Circulation (1994) 1.20
Cross-sectional echocardiography. III. Analysis of mathematic models for quantifying volume of symmetric and asymmetric left ventricles. Am Heart J (1980) 1.19
Echocardiography in serial evaluation of left ventricular systolic and diastolic function: importance of image acquisition, quantitation, and physiologic variability in clinical and investigational applications. J Am Soc Echocardiogr (1991) 1.15
Echoventriculography -- a simultaneous analysis of two-dimensional echocardiography and cineventriculography. Circulation (1983) 1.06
Systolic and diastolic heart failure: different phenotypes of the same disease? Eur J Heart Fail (2006) 1.06
Myocardial contractility in the echo lab: molecular, cellular and pathophysiological basis. Cardiovasc Ultrasound (2005) 1.04
Ventricular volume and length in hypertensive diastolic heart failure. J Am Soc Echocardiogr (2005) 1.03
End-systolic pressure determines stroke volume from fixed end-diastolic volume in the isolated canine left ventricle under a constant contractile state. Circ Res (1979) 0.94
Diastolic heart failure: a myth. Curr Opin Cardiol (2006) 0.91
"Systolic and diastolic dysfunction" in heart failure? Time for a new paradigm. J Card Fail (2003) 0.91
Left ventricular end-systolic volume index in patients with ischemic cardiomyopathy predicts postoperative ventricular function. Ann Thorac Surg (1995) 0.90
Inducible ischemia and the risk of recurrent cardiovascular events in outpatients with stable coronary heart disease: the heart and soul study. Arch Intern Med (2008) 0.88
Prognosis after recovery from myocardial infarction: the relative importance of cardiac dilatation and coronary stenoses. Eur Heart J (1992) 0.85
Accuracy of volume determination by two-dimensional echocardiography: defining requirements under controlled conditions in the ejecting canine left ventricle. Circulation (1983) 0.85
Decline in the rate of hospital mortality from acute myocardial infarction: impact of changing management strategies. Am Heart J (1996) 0.84
Use of end-systolic volume changes with exercise to detect left ventricular dysfunction in patients with coronary artery disease. Clin Cardiol (1982) 0.79
End-systolic pressure-volume relations. Circulation (1979) 0.77
Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr (2010) 13.12
Spironolactone for heart failure with preserved ejection fraction. N Engl J Med (2014) 7.48
Depressive symptoms and health-related quality of life: the Heart and Soul Study. JAMA (2003) 7.01
Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. JAMA (2008) 6.50
The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the Heart and Soul Study. Ann Intern Med (2010) 4.89
American Society of Echocardiography recommendations for use of echocardiography in clinical trials. J Am Soc Echocardiogr (2004) 4.88
Isosorbide Mononitrate in Heart Failure with Preserved Ejection Fraction. N Engl J Med (2015) 4.39
Depression screening and patient outcomes in cardiovascular care: a systematic review. JAMA (2008) 3.55
Six-minute walk test as a prognostic tool in stable coronary heart disease: data from the heart and soul study. Arch Intern Med (2012) 3.50
From the Cover: Whole-genome association study identifies STK39 as a hypertension susceptibility gene. Proc Natl Acad Sci U S A (2008) 3.39
Central nervous system-active medications and risk for falls in older women. J Am Geriatr Soc (2002) 3.03
Clinical characteristics of pulmonary hypertension in patients with heart failure and preserved ejection fraction. Circ Heart Fail (2011) 2.92
Noninvasive assessment of pulmonary vascular resistance by Doppler echocardiography. J Am Soc Echocardiogr (2013) 2.83
Additive effects of cognitive function and depressive symptoms on mortality in elderly community-living adults. J Gerontol A Biol Sci Med Sci (2003) 2.82
B-type natriuretic peptide and ischemia in patients with stable coronary disease: data from the Heart and Soul study. Circulation (2003) 2.82
Implications of hypertrophic cardiomyopathy transmitted by sperm donation. JAMA (2009) 2.77
Depression and heart rate variability in patients with stable coronary heart disease: findings from the Heart and Soul Study. Arch Gen Psychiatry (2005) 2.73
A simple method for noninvasive estimation of pulmonary vascular resistance. J Am Coll Cardiol (2003) 2.62
Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study. Circulation (2006) 2.61
Blood pressure reactivity to psychological stress predicts hypertension in the CARDIA study. Circulation (2004) 2.39
Development of an echocardiographic risk-stratification index to predict heart failure in patients with stable coronary artery disease: the Heart and Soul study. JACC Cardiovasc Imaging (2009) 2.38
Association of a serotonin transporter polymorphism (5-HTTLPR) with depression, perceived stress, and norepinephrine in patients with coronary disease: the Heart and Soul Study. Am J Psychiatry (2007) 2.37
Self-reported medication adherence and cardiovascular events in patients with stable coronary heart disease: the heart and soul study. Arch Intern Med (2007) 2.34
Vitamin D deficiency and cardiovascular events in patients with coronary heart disease: data from the Heart and Soul Study. Am J Epidemiol (2014) 2.30
Central nervous system active medications and risk for fractures in older women. Arch Intern Med (2003) 2.30
Depression and medication adherence in outpatients with coronary heart disease: findings from the Heart and Soul Study. Arch Intern Med (2005) 2.28
Association between human fetuin-A and the metabolic syndrome: data from the Heart and Soul Study. Circulation (2006) 2.27
Dose-dependent augmentation of cardiac systolic function with the selective cardiac myosin activator, omecamtiv mecarbil: a first-in-man study. Lancet (2011) 2.25
Association of fetuin-A with mitral annular calcification and aortic stenosis among persons with coronary heart disease: data from the Heart and Soul Study. Circulation (2007) 2.23
Screening for depression in patients with coronary heart disease (data from the Heart and Soul Study). Am J Cardiol (2005) 2.18
Telomere length trajectory and its determinants in persons with coronary artery disease: longitudinal findings from the heart and soul study. PLoS One (2010) 2.10
Clinical problem-solving. Anchors away. N Engl J Med (2007) 2.02
Compensatory changes in atrial volumes with normal aging: is atrial enlargement inevitable? J Am Coll Cardiol (2002) 1.99
Scared to death? Generalized anxiety disorder and cardiovascular events in patients with stable coronary heart disease:The Heart and Soul Study. Arch Gen Psychiatry (2010) 1.99
Urinary creatinine excretion rate and mortality in persons with coronary artery disease: the Heart and Soul Study. Circulation (2010) 1.97
Differential associations between specific depressive symptoms and cardiovascular prognosis in patients with stable coronary heart disease. J Am Coll Cardiol (2010) 1.96
Fractional excretion of phosphorus modifies the association between fibroblast growth factor-23 and outcomes. J Am Soc Nephrol (2013) 1.95
Depressive symptoms, health behaviors, and subsequent inflammation in patients with coronary heart disease: prospective findings from the heart and soul study. Am J Psychiatry (2011) 1.92
Prognostic value of leukocyte telomere length in patients with stable coronary artery disease: data from the Heart and Soul Study. Arterioscler Thromb Vasc Biol (2008) 1.92
Cardiovascular risk assessment of the liver transplant candidate. J Am Coll Cardiol (2011) 1.89
Blood pressure reactivity to psychological stress and coronary calcification in the Coronary Artery Risk Development in Young Adults Study. Hypertension (2006) 1.86
Relation of sex and estrogen therapy to serum fibroblast growth factor 23, serum phosphorus, and urine phosphorus: the Heart and Soul Study. Am J Kidney Dis (2011) 1.83
Usefulness of red cell distribution width as a prognostic marker in pulmonary hypertension. Am J Cardiol (2009) 1.80
Prognostic significance of increased left ventricular mass index to mortality and sudden death in patients with stable coronary heart disease (from the Heart and Soul Study). Am J Cardiol (2008) 1.75
Association between renal insufficiency and inducible ischemia in patients with coronary artery disease: the heart and soul study. J Am Soc Nephrol (2003) 1.72
Association of marine omega-3 fatty acid levels with telomeric aging in patients with coronary heart disease. JAMA (2010) 1.71
High-sensitivity cardiac troponin T levels and secondary events in outpatients with coronary heart disease from the Heart and Soul Study. JAMA Intern Med (2013) 1.62
Atrial dilation and altered function are mediated by age and diastolic function but not before the eighth decade. JACC Cardiovasc Imaging (2011) 1.57
Is B-type natriuretic peptide a useful screening test for systolic or diastolic dysfunction in patients with coronary disease? Data from the Heart and Soul Study. Am J Med (2004) 1.56
Prognostic value of low-level cardiac troponin-I elevations in patients without definite acute coronary syndromes. Am Heart J (2004) 1.55
Effects of sustained audit/feedback on self-reported health status of primary care patients. Am J Med (2004) 1.52
Fibroblast growth factor-23 and early decrements in kidney function: the Heart and Soul Study. Nephrol Dial Transplant (2009) 1.51
Alcohol consumption and 5-year change in left atrial volume among patients with coronary heart disease: results from the Heart and Soul study. J Card Fail (2013) 1.50
Depression and leukocyte telomere length in patients with coronary heart disease: data from the Heart and Soul Study. Psychosom Med (2011) 1.49
Differential association of cognitive and somatic depressive symptoms with heart rate variability in patients with stable coronary heart disease: findings from the Heart and Soul Study. Psychosom Med (2007) 1.46
Association of segmental wall motion abnormalities occurring during hemodialysis with post-dialysis fatigue. Nephrol Dial Transplant (2013) 1.45
Lack of association of chromosome 9p21.3 genotype with cardiovascular structure and function in persons with stable coronary artery disease: The Heart and Soul Study. Atherosclerosis (2008) 1.45
Comparison of left atrial volume and function after linear ablation and after cardioversion for chronic atrial fibrillation. Am J Cardiol (2004) 1.45
Association of blood pressure and heart rate response during exercise with cardiovascular events in the Heart and Soul Study. J Hypertens (2010) 1.45
Biomarkers to predict recurrent cardiovascular disease: the Heart and Soul Study. Am J Med (2008) 1.45
Association of low leptin with cardiovascular events and mortality in patients with stable coronary artery disease: the Heart and Soul Study. Atherosclerosis (2010) 1.43
Interleukin-6 and atrial fibrillation in patients with coronary artery disease: data from the Heart and Soul Study. Am Heart J (2007) 1.42
Predicting heart failure hospitalization and mortality by quantitative echocardiography: is body surface area the indexing method of choice? The Heart and Soul Study. J Am Soc Echocardiogr (2010) 1.42
Cholecystectomy in the presence of a large patent foramen ovale: laparoscopic or open? J Clin Anesth (2010) 1.41
C-reactive protein and ischemia in users and nonusers of beta-blockers and statins: data from the Heart and Soul Study. Circulation (2003) 1.40
Cardiac structure and function in heart failure with preserved ejection fraction: baseline findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist trial. Circ Heart Fail (2013) 1.40
Depression and 24-hour urinary cortisol in medical outpatients with coronary heart disease: The Heart and Soul Study. Biol Psychiatry (2004) 1.39
Association of chronic kidney disease and anemia with physical capacity: the heart and soul study. J Am Soc Nephrol (2004) 1.35
Fetuin-A and kidney function in persons with coronary artery disease--data from the Heart and Soul Study. Nephrol Dial Transplant (2006) 1.34
Racial differences in atrial fibrillation prevalence and left atrial size. Am J Med (2010) 1.32
Prevalence, clinical phenotype, and outcomes associated with normal B-type natriuretic peptide levels in heart failure with preserved ejection fraction. Am J Cardiol (2012) 1.28
Post-traumatic stress disorder is associated with poor health behaviors: findings from the heart and soul study. Health Psychol (2011) 1.27
Depression predicts mortality and hospitalization in patients with myocardial infarction complicated by heart failure. Am Heart J (2005) 1.27
Association of cystatin C and estimated GFR with inflammatory biomarkers: the Heart and Soul Study. Nephrol Dial Transplant (2007) 1.27
A functional polymorphism in renalase (Glu37Asp) is associated with cardiac hypertrophy, dysfunction, and ischemia: data from the heart and soul study. PLoS One (2010) 1.25
Depressive symptoms and perceived doctor-patient communication in the Heart and Soul study. J Gen Intern Med (2009) 1.24
Prognostic importance of pathophysiologic markers in patients with heart failure and preserved ejection fraction. Circ Heart Fail (2013) 1.22
Inverse association of erythrocyte n-3 fatty acid levels with inflammatory biomarkers in patients with stable coronary artery disease: The Heart and Soul Study. Atherosclerosis (2008) 1.22
Cystatin C, left ventricular hypertrophy, and diastolic dysfunction: data from the Heart and Soul Study. J Card Fail (2006) 1.21